How new periodontal therapies are developed and evaluated.
Br Dent J
; 182(4): 149-52, 1997 Feb 22.
Article
en En
| MEDLINE
| ID: mdl-9062003
ABSTRACT
General dental practitioners comprise the target market for manufacturers wishing to sell new therapies for the treatment of periodontal disease. However, because of the often limited information supplied by manufactures, GDPs may be unable to make informed decisions about whether a new product can benefit their patients and practice. This article explains the stages of clinical research undertaken before products can be marketed and discusses a potential role for GDPs in clinical research.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Enfermedades Periodontales
/
Ensayos Clínicos como Asunto
/
Evaluación de Medicamentos
Tipo de estudio:
Prognostic_studies
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Br Dent J
Año:
1997
Tipo del documento:
Article